Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.

Maiko Noguchi; Hiroshi Moritake; Sachiyo Kamimura; Motoshi Sonoda; Masataka Ishimura; Jiro Inagaki

首页> 外文期刊>Bone marrow transplantation >Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.

【24h】

Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.

机译：服用Behcet疾病和继发性骨髓增生综合征在一个男孩中的无关骨髓移植术后血糖综合征治疗Adalimumab。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2018年第9期|共4页
作者
Maiko Noguchi; Hiroshi Moritake; Sachiyo Kamimura; Motoshi Sonoda; Masataka Ishimura; Jiro Inagaki;
展开▼
作者单位

Department of Pediatrics National Kyushu Cancer Center Fukuoka Japan;

Division of Pediatrics Faculty of Medicine University of Miyazaki Miyazaki Japan;

Division of Pediatrics Faculty of Medicine University of Miyazaki Miyazaki Japan;

Department of Pediatrics Graduate School of Medical Sciences Kyushu University Fukuoka Japan;

Department of Pediatrics Graduate School of Medical Sciences Kyushu University Fukuoka Japan;

Department of Pediatrics National Kyushu Cancer Center Fukuoka Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome. [J] . Maiko Noguchi, Hiroshi Moritake, Sachiyo Kamimura, Bone marrow transplantation . 2018,第9期

机译：服用Behcet疾病和继发性骨髓增生综合征在一个男孩中的无关骨髓移植术后血糖综合征治疗Adalimumab。
2. Allogeneic bone marrow transplantation for active Epstein-Barr virus-related lymphoproliferative disease and hemophagocytic lymphohistiocytosis in an infant with severe combined immunodeficiency syndrome. [J] . Schmid I, Reiter K, Schuster F, Bone marrow transplantation . 2002,第6期

机译：同种异体骨髓移植治疗活动性爱泼斯坦-巴尔病毒相关的淋巴增生性疾病和严重合并免疫缺陷综合征婴儿的噬血细胞淋巴组织细胞增生。
3. Unrelated bone marrow transplantation using a reduced-intensity conditioning regimen for the treatment of Kostmann syndrome. [J] . Fukano R, Nagatoshi Y, Shinkoda Y, Bone marrow transplantation . 2006,第9期

机译：使用降低强度的调理方案进行的无关的骨髓移植，用于治疗Kostmann综合征。
4. Anti-Thymocyte-Globulin (ATG-Fresenius) for Prevention of Acute and Chronic Graft-versus-Host Disease in Pediatric and Adult Recipients of Unrelated Donor Bone Marrow Transplantation [C] . . 2006

机译：抗胸腺细胞球蛋白（ATG-Fresenius）预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
5. Chronic Bone Marrow Failure and Transfusion Patterns: Epidemiological Studies of Blood Transfusions and Outcomes in Patients with Myelodysplastic Syndromes [D] . Rydén, Jenny. 2021

机译：慢性骨髓衰竭和输血模式：骨髓增生综合征患者出血和结果的流行病学研究
6. Impact of the revised International Prognostic Scoring System cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation [O] . Christian Koenecke, Gudrun Göhring, Liesbeth C. de Wreede, 2015

机译：修订后的国际预后评分系统细胞遗传学和单核染色体核型对骨髓增生异常综合症和继发于骨髓增生异常综合症的继发性急性髓性白血病的同种异体干细胞移植后结局的影响：欧洲血液和骨髓移植学会的一项回顾性多中心研究
7. Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome [O] . Ho, A Y L, Adams, S, Shaikh, H, 2002

机译：降低强度的志愿者无关的骨髓移植治疗骨髓增生异常综合症后，致命的供体来源的爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病

Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.

著录项

相似文献

相关主题

期刊订阅